1. Academic Validation
  2. Nuclear translocation of PKM2 mediates keratinocyte metabolic reprogramming in psoriasis

Nuclear translocation of PKM2 mediates keratinocyte metabolic reprogramming in psoriasis

  • Exp Dermatol. 2023 Sep 8. doi: 10.1111/exd.14922.
Luting Yang 1 Jie Zhang 1 Chunqing Hu 1 Xiaowen Chen 1 Yang Yang 1 Huihao Tang 2 3 Xiaolei Ding 2 3 Yaping Yan 1
Affiliations

Affiliations

  • 1 Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
  • 2 Institute of Geriatrics, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, Nantong, China.
  • 3 Shanghai Engineering Research Center of Organ Repair, School of Medicine, Shanghai University, Shanghai, China.
Abstract

PKM2 mediates the Warburg effects and is crucial for tumorigenesis, but its role in hyperplastic skin disorders remains elusive. In this study, we investigated the function of PKM2 in psoriatic keratinocytes. We found that PKM2 expression and its nuclear translocation were induced in the epidermis of psoriasis patients, contributing to aerobic glycolysis and cell growth. Moreover, mass spectrometry combined with immunoprecipitation analysis revealed that PKM2 could interact with TRIM33, an E3 ubiquitin ligase in the nucleus, and this interaction is critical for the nuclear retention of PKM2. As a result of TRIM33-mediated ubiquitination, PKM2 nuclear protein kinase function is promoted, thus leading to the phosphorylation of STAT3. In addition, blocking PKM2 nuclear translocation abrogated TRIM33-triggered glycolysis and cell proliferation in keratinocytes. Taken together, our experiments demonstrate that ubiquitination regulates the nuclear retention of PKM2 in keratinocytes. Moreover, our results highlight a novel mechanism accounting for the metabolic reprogramming of keratinocytes in psoriasis patients.

Keywords

keratinocyte; metabolic reprogramming; psoriasis; pyruvate kinase M2; ubiquitination.

Figures
Products